四位拥有投票权的地方联储主席对12月再度降息并不积极 乌外交部：至少在年底前不会与俄方进行和平谈判 中方将继续延长实施对西班牙免签政策，便利人员往来 国家能源局发布促进新能源集成融合发展的指导意见 证监会：境外投资者持有A股市值超3.5万亿元 男生普通话版 下载mp3 女声普通话版 下载mp3 粤语版 下载mp3 西南方言版 下载mp3 东北话版 下载mp3 上海话版 下载mp3 今日优选 众议院将于北京时间13日8:00就结束政府停摆的法案进行全院投票 白宫：10月非农与通胀数据可能永远不会公布 亚特兰大联储主席博斯蒂克意外宣布将退休 中国光伏行业协会声明：网络流传的小道消息均为不实信息 市场盘点 周三，因交易员们评估美国政府恢复运转后，大量经济数据公布将对美联储利率政策产生何种影响，美元指数先涨后跌，最终接近平收，报99.46；基准的 10年期美债收益最终收报4.075%，对美联储政策利率敏感的2年期美债收益率收报3.576%；美元兑日元一度站上155，为2月以来首次。 现货黄金在美盘时段强势上涨，日内涨近100美元并一度重回4200关口上方，但未能站稳此处，最终收涨1.65%，收报4194.40美元/盎 ...

A股深"V" 11月12日，A股全天探底回升，三大指数小幅下跌。截至收盘，沪指跌0.07%，深成指跌0.36%，创业板 指跌0.39%。 市场共1758只个股上涨，77只个股涨停，3563只个股下跌。 医药股集体走强，细胞免疫治疗方向领涨，开能健康、济民健康等多股涨停。 油气股全天强势，石化油服、准油股份封板。 银行板块冲高，农业银行、工商银行齐创历史新高。 （原标题：光伏小作文搅动市场！医药股集体走强 油气股全天强势） 今天的市场，深"V"大逆转，一起看看发生了什么事情。 光伏小作文搅动市场 12日，市场流传一篇关于光伏反内卷的小作文，搅乱了市场情绪。 受此影响，午后光伏、储能概念股持续调整，通威股份触及跌停，阿特斯、艾罗能源跌超10%，双良节 能、晶澳科技、隆基绿能、天合光能跌幅靠前。 随后，中国光伏行业协会官微紧急发布声明称，协会在相关部委的坚强指导下努力推进行业自律和"反 内卷"工作：从供需两端共同发力，市场化、法制化地推动相关工作。协会始终坚信，在中央坚定指导 支持下，行业，企业积极协调配合下，相关工作一定会成功。 当下，协会和行业内各企业正一道努力，相关工作正在稳步推进。网络流传的小道消息均为不实 ...

盘面上，市场热点快速轮动，全市场超3500只个股下跌。从板块来看， 防御性板块集体走强 ，其中油气概念爆发，石化油服、准油股份双双涨停。 医药板块持续走高 ，细胞免疫治疗概念领涨，开能健康、济民健康等多股涨停。银行板块表现强势，农业银行、工商银行双双创历史新高。消费板 块局部活跃，三元股份、中锐股份3连板，东百集团6天4板。锂电板块尾盘拉升，天际股份4天3板。下跌方面，超硬材料股集体大跌，沃尔德跌超 10%。 板块方面，保险、医药、油气等板块涨幅居前，培育钻石、光伏、可控核聚变等板块跌幅居前。 截至收盘，沪指跌0.07%，深成指跌0.36%，创业板指跌0.39%。 | 上证指数 | | 深证成指 | 创业板指 | | --- | --- | --- | --- | | -4000.14 | | · 13240.61 | -3122.03 | | 2.62 | -0.07% | -48.39 -0.36% | -12.29 -0.39% | | 11 | | THE | 7 / 11 | 市场概况 今日A股市场探底回升，沪指微跌，创业板指尾盘一度翻红。沪深两市成交额1.95万亿，较上一个交易日缩量486亿。 2 ...

Core Viewpoint - The company held its 2024 Annual General Meeting, discussing various operational and financial aspects, including a slight increase in revenue but a significant decrease in net profit, alongside strategic plans for future growth in various sectors [1][21][24]. Group 1: Meeting Details - The 2024 Annual General Meeting is scheduled for May 21, 2025, at 13:30 in Nanjing [1]. - The meeting will include both on-site and online voting methods [4]. - Legal opinions will be provided by Jiangsu Taihe Law Firm during the meeting [3][4]. Group 2: Financial Performance - The company achieved an operating revenue of 6.7 billion yuan, a year-on-year increase of 1.98%, with the main business revenue accounting for 95.91% [5][21]. - The net profit attributable to shareholders was 230 million yuan, a decrease of 46.10% compared to the previous year [21][24]. - The total assets of the company reached 26.225 billion yuan, with total liabilities of 7.132 billion yuan [23]. Group 3: Business Segments - The main business sectors include commercial retail, hospitality, health and elderly care, professional technical services, pharmaceutical manufacturing, and medical services [5][21]. - The commercial sector reported a revenue of 412 million yuan, down 11.27% year-on-year [22]. - The health and elderly care sector generated 2.128 billion yuan, with a slight decrease of 0.11% [22]. Group 4: Strategic Initiatives - The company is focusing on enhancing its core business capabilities and expanding its market presence in health and elderly care services, as well as in the biomedical sector [26][29]. - Plans include upgrading retail spaces and introducing new brands to improve customer experience [29]. - The company aims to retain undistributed profits for future investments in market expansion and R&D [31]. Group 5: Governance and Compliance - The board of directors held eight meetings during the reporting period, ensuring compliance with legal and regulatory requirements [9][12]. - The independent directors actively participated in decision-making and oversight, contributing to the company's stable development [14][15]. - The company has established a robust internal control system to manage operational risks effectively [16][20]. Group 6: Future Outlook - The company anticipates continued growth in the health and elderly care market, driven by an aging population and increasing consumer demand [25][27]. - The biomedical sector is expected to expand significantly, supported by government policies promoting stem cell technology and clinical applications [26][28]. - The retail business is undergoing transformation to adapt to market changes and consumer preferences, aiming for sustainable growth [29][31].